XOCT yields 5.37% · JNJ yields 3.36%● Live data
📍 XOCT pulled ahead of the other in Year 1
Combined, XOCT + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of XOCT + JNJ for your $10,000?
The investment objective of the FT Vest U.S. Equity Enhance & Moderate Buffer ETF - October (the "Fund") is to seek to provide investors with returns (before fees and expenses) of approximately twice any positive price return of the SPDR S&P 500 ETF Trust (the "Underlying ETF"), up to a predetermined upside cap of 10.26% while providing a buffer (before fees and expenses) against the first 15% of Underlying ETF losses, over the period from October 20, 2025 to October 16, 2026.
Full XOCT Calculator →Johnson & Johnson is a Dividend King with 62+ years of consecutive dividend increases. A healthcare conglomerate spanning pharmaceuticals, MedTech, and consumer health. JNJ spun off its consumer segment as Kenvue in 2023, focusing on higher-margin pharma and medical devices.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.